Innovac Therapeutics Completes $18 million Series Pre-A Fina

/PRNewswire/ -- Innovac Therapeutics, an mRNA therapeutics company, today announced the completion of an $18 million Series Pre-A financing. The financing...

Related Keywords

Boston , Massachusetts , United States , Cincinnati , Ohio , Ohio State University , Hangzhou , Zhejiang , China , Shan Lu , Fujian , Shanghai , University Of Massachusetts Medical School , Michael Zhang , Nicholas Valiante , David Bernstein , Elaine Mardis , Gamble Program At Cincinnati Children Hospital , Temasek Holdings , University Of Cincinati Department Pediatrics , Ohio State University College Of Medicine , Umass Chan Medical School , Tg Sino Dragon Fund , Laboratory Of Nucleic Acid Vaccines , Series Pre A , Elikon Venture , Vision Plus Capital , Yunion Healthcare Ventures , Dragon Fund , Chief Scientific Officer , Global Head , Zhang Yuan , Chief Technical Officer , Chemistry Manufacturing , Innovac Therapeutics , Gamble Program , Cincinnati Children , Vaccine Testing , Evaluation Unit , Cincinati Department , Nucleic Acid Vaccines , Massachusetts Medical School , Professor Emeritus , Chan Medical , Genomic Medicine , Nationwide Children , Ohio State University College , Cancer Genome , Healthcare Ventures , Banking Amp Financial Services , Biotechnology , Health Care Amp Hospitals , Medical Pharmaceuticals , Financing Agreements ,